| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441663 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
AC overexpression is associated with cisplatin sensitivity, suggesting its potential role as a chemotherapeutic target for HNC. Genetic or pharmacological AC inhibition promotes cisplatin cytotoxicity in HNC cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jong-Lyel Roh, Jin Young Park, Eun Hye Kim, Hye Jin Jang,